{"id":"W2155242348","doi":"10.1177/2048872614527838","title":"Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial","year":2014,"lang":"en","type":"article","venue":"European Heart Journal Acute Cardiovascular Care","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cardiology; Acute coronary syndrome; Internal medicine; Elevation (ballistics); Antagonist; Platelet; Platelet activation; ST elevation; Thrombin; Receptor antagonist; Receptor; Electrocardiography; Myocardial infarction; Engineering","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001540563,0.0003894061,0.001156698,0.0002180046,0.0001256881,0.0007576615,0.0003482143,0.0005573632,0.0009579363],"category_scores_gemma":[0.001909211,0.0001476443,0.001052105,0.0003523924,0.0003812285,0.0003480631,0.0002214455,0.0005217763,0.000133407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005555846,"about_ca_system_score_gemma":0.0005282364,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001353344,"about_ca_topic_score_gemma":0.002796482,"domain_scores_codex":[0.999437,0.0003589192,0.00003496629,0.00006162069,0.00006055801,0.0000469209],"domain_scores_gemma":[0.9989339,0.0003444348,0.0003911121,0.00007161478,0.00006684379,0.0001922764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7205001,0.002550773,0.1874255,0.001687056,0.01121776,0.0002612617,0.0002315014,0.001443097,0.005655115,0.0006772474,0.00397176,0.06437885],"study_design_scores_gemma":[0.4060686,0.07904001,0.487958,0.0006130115,0.01331353,0.0006631871,0.0002593531,0.003241226,0.001175731,0.0009571055,0.00659694,0.0001132754],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885598,0.009927278,0.00009090827,0.0002775209,0.00005780808,0.00006898547,0.0004178627,0.00001411731,0.0005856485],"genre_scores_gemma":[0.9951426,0.002549055,0.0002434819,0.0002869704,0.0001627373,0.00009106223,0.001276049,0.000004410305,0.0002436875],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001540563,"threshold_uncertainty_score":0.008147359,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01072225702901207,"score_gpt":0.2265749162038676,"score_spread":0.2158526591748555,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}